Depuis le démarrage de notre activité de capital - investissement en 1989, nous avons investi dans plus de 335 sociétés réparties dans 40 pays.
| Société | Pays | Secteur | Description | Type de deal | Date de l'investissement | |
|---|---|---|---|---|---|---|
 |
ICE Pharma
|
Pays Italy | Secteur Santé | Description A global leader in the production of Ursodeoxycholic Acid (UDCA) used for the treatment of gastric and chronic diseases | Type de deal Buyout | Date de l'investissement Sep 2019 |
 |
Zentiva
|
Pays Czech Republic | Secteur Santé | Description A leading European generics pharmaceutical company, offering generic medicines across all key therapeutic areas | Type de deal Détourage | Date de l'investissement Sep 2018 |
 |
Mediq
|
Pays Netherlands | Secteur Santé | Description Global provider of pharmaceuticals, medical devices and related care services | Type de deal Public-to-private | Date de l'investissement Feb 2013 |
 |
Labormed
|
Pays Romania | Secteur Santé | Description Romanian pharmaceutical manufacturer and distributor | Type de deal Buyout | Date de l'investissement Feb 2008 |
 |
Terapia
|
Pays Romania | Secteur Santé | Description Romania's largest independent generic pharmaceuticals manufacturer | Type de deal Public-to-private | Date de l'investissement Aug 2003 |
 |
Aviagen
|
Pays United Kingdom | Secteur Santé | Description World's leading meat poultry breeding company | Type de deal Buyout | Date de l'investissement May 2003 |
 |
Viatris
|
Pays Germany | Secteur Santé | Description Development, manufacturing, distribution and in-licensing of branded pharmaceuticals | Type de deal Détourage | Date de l'investissement Aug 2002 |
 |
Tropon
|
Pays Germany | Secteur Santé | Description Toll manufacturer and supplier of drugs for inflammatory and rheumatoid disorders (acquired by Advent portfolio company Viatris) | Type de deal Détourage | Date de l'investissement Mar 2000 |
 |
Alcala Farma
|
Pays Spain | Secteur Santé | Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products | Type de deal Growth equity | Date de l'investissement Sep 1999 |
 |
Trinity Pharmaceuticals
|
Pays United Kingdom | Secteur Santé | Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications | Type de deal Détourage | Date de l'investissement Mar 1997 |
 |
Esaote Biomedica
|
Pays Italy | Secteur Santé | Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment | Type de deal Privatization | Date de l'investissement Jul 1994 |
© 2002-2024 Advent International, L.P. All rights reserved
